News for 'BSE Healthcare'

CAD fuels market to record highs; Nifty ends above 6400

CAD fuels market to record highs; Nifty ends above 6400

Rediff.com6 Mar 2014

Investors cheered a sharp decline in the Current Account Deficit, which stands at a 4 year low as exports picked up and gold imports reduced.

Stocks falter on rate hike fears; realty, power tank

Stocks falter on rate hike fears; realty, power tank

Rediff.com4 Jun 2018

HDFC Bank was the top loser in the Sensex pack, falling 2.99 per cent, followed by Adani Ports at 2.87 per cent.

Markets slip from record to end flat on profit-booking

Markets slip from record to end flat on profit-booking

Rediff.com13 Jul 2018

Notable losers were ONGC, Axis Bank, ITC, SBI, ICICI Bank, NTPC, Hero Motocorp, Sun Pharma and Bharti Airtel who fell by up to 2.80 per cent.

Sensex ends at 2-month high on ECB stimulus hopes

Sensex ends at 2-month high on ECB stimulus hopes

Rediff.com23 Oct 2015

The 30 share Sensex ended up 183 points at 27,470 and the 50-share Nifty gained 44 points to close at 8,295.

5 factors that may help markets scale new highs

5 factors that may help markets scale new highs

Rediff.com29 Jan 2021

Market participants are hoping for a few tweaks on the taxation front which will encourage consumers and businesses to spend.

Markets trim gains to end flat

Markets trim gains to end flat

Rediff.com25 Jan 2016

Benchmark share indices trimmed intra-day gains after global crude oil prices resumed their downward trajectory after sharp gains on Friday.

Sensex ends in the red amid volatile trade; IT, auto, realty fall

Sensex ends in the red amid volatile trade; IT, auto, realty fall

Rediff.com24 Mar 2015

The 30-share Sensex ended down 30.30 points at 28,161.72 and the 50-share Nifty dipped 7.95 points at 8,543.

Weak rupee, China woes drag Sensex below 25,000; Nifty breaches 7,600

Weak rupee, China woes drag Sensex below 25,000; Nifty breaches 7,600

Rediff.com7 Sep 2015

The Sensex closed down 308 points at 24,894 and the Nifty has lost 96 points at 7,559.

'Both BJP and Congress are indulging in competitive populism to woo voters'

'Both BJP and Congress are indulging in competitive populism to woo voters'

Rediff.com9 Apr 2019

There will be pressure on the fiscal situation, especially at a time when the monsoon can also disappoint. More populist expenditure is on cards if the mandate is a hung Parliament or a coalition government.

PE major Advent snaps up Eureka Forbes for Rs 4,400 cr

PE major Advent snaps up Eureka Forbes for Rs 4,400 cr

Rediff.com20 Sep 2021

After a long wait, the Shapoorji Pallonji Group has closed the sale process of its consumer durables business under the Eureka Forbes label by picking the American private equity fund Advent International's Rs 4,400-crore offer for a 72 per cent stake. The sale process, which began in November 2019, will help the over 156-year-old SP Group pair the debt pile and sharpen the focus on the flagship construction and engineering business under Afcons. The valuation of Rs 4,400 crore for a 72.56 per cent stake is is at an enterprise level and subject to closing adjustments and also includes an open offer for the remaining stake after the demerger and listing of Eureka Forbes, the SP group said in a statement on Sunday.

2017 was best year for equities in 3 years

2017 was best year for equities in 3 years

Rediff.com30 Dec 2017

In absolute terms, the year closed with the market capitalisation of all BSE-listed companies rising by Rs 45.5 lakh crore to Rs 152 lakh crore, or an increase of 42.8 per cent, compared to the closing value on December 30, 2016, says Pavan Burugula.

Markets end marginally lower as investors stay wary on corporate results

Markets end marginally lower as investors stay wary on corporate results

Rediff.com17 Apr 2017

NTPC, Sun Pharma Coal India and Asian Paints were among top losers on BSE Sensex

Cadila Health, to merge with German Remedies

Cadila Health, to merge with German Remedies

Rediff.com15 Jan 2003

Cadila Health, to merge with German Remedies

Sensex ends below 28,000 as rate cut hopes dim

Sensex ends below 28,000 as rate cut hopes dim

Rediff.com22 Aug 2016

Urjit Patel as the new RBI governor whose focus is on taming inflation has lowered the probability of interest rate cut soon

Wockhardt to recall some drugs made in India

Wockhardt to recall some drugs made in India

Rediff.com28 Apr 2015

Wockhardt is recalling select drugs in the US, which were under import restrictions from the USFDA.

Sensex ends in green; GDP data awaited

Sensex ends in green; GDP data awaited

Rediff.com27 Nov 2014

The 30-share Sensex ended 53 points higher at 28,439 and the 50-share Nifty closed 18 points higher at 8,494.

Markets hit over 6-month low as rupee woes, trade war worries linger

Markets hit over 6-month low as rupee woes, trade war worries linger

Rediff.com23 Oct 2018

Geo-political concerns over death of a Saudi journalist, Brexit and likely breach in Italy's budget also kept investors cautious.

HSBC cautious on India; Sensex year-end target at 20,250

HSBC cautious on India; Sensex year-end target at 20,250

Rediff.com10 Oct 2013

Slowing economy, election-related uncertainty and tighter monetary conditions pose risks for Indian markets and the BSE index, Sensex, is likely to hover around 20,250 by the end of this year.

Expertview: Sectors that will drive markets in 2021

Expertview: Sectors that will drive markets in 2021

Rediff.com11 Dec 2020

While analysts remains overweight on financials, property, discretionary, industrials and materials, they maintain a neutral stance on pharma, telecom and energy; and underweight on staples, utilities, and IT services.

Sensex logs this year's biggest fall; ITC slumps 13%

Sensex logs this year's biggest fall; ITC slumps 13%

Rediff.com18 Jul 2017

The market sentiment was also impacted by mixed global cues as setbacks for a healthcare overhaul in the US raised doubts over prospects for a range of reforms backed by President Donald Trump.

Sensex: How long will the good times last?

Sensex: How long will the good times last?

Rediff.com26 Dec 2021

As if wanting to be an antidote to the coronavirus pandemic, the Indian stock market adorned carnival robes in 2021 with a tsunami of liquidity unleashed by global central banks coupled with supportive domestic policies and the world's largest vaccination drive sparking off a world-beating rally on Dalal Street, despite bouts of uneasiness over fizzy valuations. While the wider economy shuttled between recovery and relapse, dictated by multiple mutations of the virus, equity market benchmarks appeared headed in just one direction -- skywards. The dizzying upward journey has added a whopping Rs 72 lakh crore during 2021 to investors' wealth, measured as the cumulative value of all listed shares in the country, taking it to nearly Rs 260 lakh crore.

GlaxoSmithkline Consumer FY-02 results on Jan 31

GlaxoSmithkline Consumer FY-02 results on Jan 31

Rediff.com15 Jan 2003

A meeting of the board of directors of GlaxoSmithkline Consumer Healthcare Ltd is scheduled on January 31, 2003, inter alia, to consider and adopt the audited financial results for the year ended December 31, 2002.\n\n\n\n

Sensex tanks 194 points after Survey projects lower GDP

Sensex tanks 194 points after Survey projects lower GDP

Rediff.com31 Jan 2017

TCS, Wipro and Infosys dropped by up to 4.47 per cent, dragging down the BSE IT index by 2.96 per cent

Earnings optimism propels markets to new highs

Earnings optimism propels markets to new highs

Rediff.com11 Jan 2018

The BSE Sensex jumped 70.42 points to end at 34,503.49, while the broader NSE Nifty finished at 10,651.20, up 19 points.

Sensex ends shy of 26K ahead of US Fed meet; Metal shares drag

Sensex ends shy of 26K ahead of US Fed meet; Metal shares drag

Rediff.com23 Nov 2015

The winter session of Parliament will commence on November 26.

Joe Biden: A long-time friend of India

Joe Biden: A long-time friend of India

Rediff.com8 Nov 2020

United States President-elect Joseph Biden has always been a strong supporter of India and India-US partnership since his days in Senate and later as a Vice-President.

Bloodbath on D-Street; Rs 6 lakh crore vanishes in 7 days

Bloodbath on D-Street; Rs 6 lakh crore vanishes in 7 days

Rediff.com27 Sep 2017

In the longest losing streak of 2017, the BSE Sensex has lost 1,270 points, or 3.91 per cent. It fell to a three-month low of 31,154.03 on Wednesday.

Why one shouldn't overreact to Sensex movements

Why one shouldn't overreact to Sensex movements

Rediff.com8 Dec 2014

Investors often forget that the movements in indices such as the Sensex reflects the performance of its constituent stocks; nothing else.

The REAL story behind zero #MeToo cases

The REAL story behind zero #MeToo cases

Rediff.com16 Nov 2018

Audit firms such as KPMG believe zero complaints may be an indicator of the lack of requisite mechanism to allow for such reporting

Hinduja family feud: $11 billion empire at stake

Hinduja family feud: $11 billion empire at stake

Rediff.com25 Jun 2020

Four Hinduja brothers -- Srichand, Gopichand, Prakash and Ashok -- had in 2014 signed on a document saying the assets held by one brother belong to all, and that each of them will appoint the others as their executors. But now family patriarch Srichand Hinduja, 84, and his daughter Vinoo want the letter to be declared of "no legal effect" and the family's assets be separated as per his wish of 2016.

Primary market off to best start in 3 years

Primary market off to best start in 3 years

Rediff.com11 Apr 2019

Going ahead, experts say, the fundraising trend in the primary market will depend on how the secondary market performs against the backdrop of the outcome of general elections and global cues.

Markets in the red ahead of July F&O expiry

Markets in the red ahead of July F&O expiry

Rediff.com31 Jul 2014

Markets ended lower following expiry of July F&O contracts and sales by foreign funds.

Stocks You Must AVOID or EXIT

Stocks You Must AVOID or EXIT

Rediff.com26 Apr 2022

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.

Trump policies no threat, say Indian drug companies

Trump policies no threat, say Indian drug companies

Rediff.com13 Jan 2017

In his press conference on Wednesday, Trump targeted drug-makers and vowed to bring back production in the US.

Sensex ends 240 points lower on rising India-Pak tension

Sensex ends 240 points lower on rising India-Pak tension

Rediff.com26 Feb 2019

Among Sensex constituents, HCL Tech suffered the most by diving 2.26 per cent, followed by HDFC shedding 2.10 per cent.

Sensex extends gains in choppy trade; up 132 points

Sensex extends gains in choppy trade; up 132 points

Rediff.com15 Oct 2018

The NSE index Nifty ended above the 10,500-mark.

Rangebound Sensex ends flat

Rangebound Sensex ends flat

Rediff.com1 Oct 2009

The NSE Nifty ended flat at 5,083 points. The market breadth was negative, out of 2,868 shares traded, 1,663 declined and 1,123 advanced on the BSE.

Sensex crashes 550 pts on rupee woes, rising crude concerns

Sensex crashes 550 pts on rupee woes, rising crude concerns

Rediff.com3 Oct 2018

In the Sensex pack, M&M was the biggest loser, tumbling by 6.66 per cent, followed by TCS dropping 4.14 per cent.

HCL Tech Q4 net slips 9.8% to Rs 2,230 crore

HCL Tech Q4 net slips 9.8% to Rs 2,230 crore

Rediff.com2 May 2018

The company's total income was up 2.2 per cent to Rs 13,480 crore in the quarter under review from Rs 13,183 crore in the corresponding quarter last year

Stocks log steady gains amid Trump turmoil

Stocks log steady gains amid Trump turmoil

Rediff.com9 May 2018

The BSE Sensex moved up 103 points to 35,319.35, while the wider NSE Nifty finished at 10,741.70, up 23.90 points.